Laporan Laba Rugi (TTM)
Laporan Laba Rugi OncoSil Medical Limited - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Change (%) | -11.01 | -20.70 | -26.10 | -0.46 | -0.46 | -8.67 | -9.49 | 9.43 | 8.62 | 8.05 | 7.45 | -5.75 | -6.11 | 10.27 | 9.32 | 11.01 | 9.92 | -9.81 | -10.88 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Change (%) | 100.00 | 402.86 | 80.11 | 15.90 | 13.72 | -11.61 | -13.13 | 7.50 | 6.98 | 21.03 | 17.37 | 8.92 | 8.19 | -9.68 | -10.72 | 4.76 | 4.54 | 18.15 | 15.36 | |
| % of Revenue | 2.13 | 4.79 | 30.37 | 74.02 | 86.18 | 98.46 | 95.29 | 91.45 | 89.84 | 88.48 | 99.11 | 108.27 | 125.13 | 144.18 | 118.09 | 96.45 | 91.02 | 86.57 | 113.40 | 146.79 |
| Gross Operating Profit | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -1 | -0 | 0 | 0 | 0 | -0 | -1 |
| Change (%) | -13.43 | -42.01 | -72.43 | -47.06 | -88.89 | 179.16 | 64.17 | 30.06 | 23.11 | -91.68 | -1,102.42 | 186.39 | 65.08 | -54.85 | -121.48 | 180.58 | 64.36 | -190.00 | 211.11 | |
| % of Revenue | 97.87 | 95.21 | 69.63 | 25.98 | 13.82 | 1.54 | 4.71 | 8.55 | 10.16 | 11.52 | 0.89 | -8.27 | -25.13 | -44.18 | -18.09 | 3.55 | 8.98 | 13.43 | -13.40 | -46.79 |
| SG&A | 4 | 5 | 6 | 8 | 8 | 9 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 9 | 10 | 10 | 10 | 10 |
| Change (%) | 13.89 | 37.08 | 27.05 | 4.69 | 4.48 | -2.57 | -2.64 | -1.41 | -1.43 | 1.89 | 1.85 | 0.18 | 0.18 | 3.91 | 3.77 | 5.57 | 5.28 | 0.50 | 0.50 | |
| % of Revenue | 161.83 | 207.11 | 358.01 | 615.52 | 647.37 | 679.52 | 724.89 | 779.79 | 702.56 | 637.58 | 601.23 | 569.92 | 605.80 | 646.34 | 609.07 | 578.14 | 549.83 | 526.62 | 586.83 | 661.74 |
| R&D | 4 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
| Change (%) | -3.81 | -8.17 | -8.90 | -6.22 | -6.63 | -3.01 | -3.10 | 7.58 | 7.05 | 2.09 | 2.04 | -2.84 | -2.92 | 5.59 | 5.29 | -3.31 | -3.42 | 25.41 | 20.26 | |
| % of Revenue | 144.15 | 155.81 | 180.42 | 222.42 | 209.56 | 196.58 | 208.75 | 223.48 | 219.71 | 216.53 | 204.58 | 194.29 | 200.30 | 207.09 | 198.29 | 190.99 | 166.36 | 146.18 | 203.26 | 274.28 |
| OpEx | 8 | 8 | 10 | 12 | 12 | 13 | 12 | 12 | 12 | 12 | 12 | 13 | 13 | 13 | 13 | 14 | 14 | 15 | 16 | 17 |
| Change (%) | 6.20 | 22.67 | 18.48 | 2.94 | 2.86 | -3.57 | -3.70 | 1.17 | 1.16 | 3.73 | 3.59 | 0.59 | 0.59 | 2.30 | 2.25 | 3.52 | 3.40 | 7.31 | 6.81 | |
| % of Revenue | 308.11 | 367.70 | 568.79 | 911.96 | 943.11 | 974.55 | 1,028.93 | 1,094.72 | 1,012.10 | 942.60 | 904.93 | 872.48 | 931.23 | 997.62 | 925.45 | 865.58 | 807.21 | 759.37 | 903.49 | 1,082.80 |
| Operating Income | -5 | -6 | -8 | -11 | -11 | -11 | -11 | -11 | -11 | -11 | -11 | -11 | -11 | -12 | -12 | -12 | -12 | -13 | -14 | -15 |
| Change (%) | 14.47 | 38.87 | 27.99 | 3.36 | 3.25 | -2.99 | -3.08 | 0.34 | 0.34 | 3.22 | 3.12 | 1.41 | 1.39 | 1.41 | 1.39 | 2.55 | 2.48 | 9.90 | 9.01 | |
| % of Revenue | -208.11 | -267.70 | -468.79 | -811.96 | -843.11 | -874.55 | -928.93 | -994.72 | -912.10 | -842.60 | -804.93 | -772.48 | -831.23 | -897.62 | -825.45 | -765.58 | -707.21 | -659.37 | -803.49 | -982.80 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||
| Change (%) | -3.35 | -16.89 | -20.33 | 25.18 | 20.11 | -8.56 | -9.35 | -11.79 | -13.36 | -13.66 | -15.82 | -7.05 | -7.59 | -22.08 | -45.94 | -62.32 | ||||
| % of Revenue | -0.99 | -1.07 | -1.12 | -1.21 | -1.53 | -1.84 | -1.84 | -1.85 | -1.49 | -1.19 | -0.95 | -0.74 | -0.73 | -0.72 | -0.51 | -0.25 | -0.09 | -0.06 | ||
| Net Income | -5 | -6 | -8 | -10 | -11 | -11 | -11 | -11 | -11 | -11 | -11 | -11 | -12 | -12 | -12 | -12 | -12 | -13 | -14 | -15 |
| Change (%) | 13.62 | 43.05 | 30.09 | 4.55 | 4.35 | -2.88 | -2.97 | -0.19 | -0.19 | 3.08 | 2.99 | 1.61 | 1.58 | 0.88 | 0.87 | 2.90 | 2.81 | 9.90 | 9.01 | |
| % of Revenue | -198.18 | -253.04 | -456.46 | -803.61 | -844.04 | -884.84 | -940.91 | -1,008.73 | -919.99 | -845.34 | -806.47 | -772.98 | -833.35 | -901.58 | -824.78 | -761.07 | -705.44 | -659.86 | -804.09 | -983.53 |
Source: Capital IQ
